Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Agalsidase beta in Cardiac Fabry Disease
NCT00140621Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jul 2005
- Primary completion
- Aug 2012
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of agalsidase beta in Fabry disease (FD), sponsored by Sanofi. Started Jul 2005; status: completed.
02
Drugs
agalsidase beta
03
Conditions
Fabry disease (FD)
Beyond the preview
Go deeper on NCT00140621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00140621.